Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31670750

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2020 Jan 1
First author
Cercek A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2020 Jan 1;6(1):29-31. doi: 10.1001/jamaoncol.2019.3691.
    note
    Source null
    related pmid
    31670748
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2020 Jun 1;6(6):935. doi: 10.1001/jamaoncol.2020.0340.
    note
    Source null
    related pmid
    32271359
    relationship
    Comment in
  3. citation
    JAMA Oncol. 2020 Jun 1;6(6):935-936. doi: 10.1001/jamaoncol.2020.0343.
    note
    Source null
    related pmid
    32271367
    relationship
    Comment in

Authors and identifiers

  1. name
    Cercek A
    type
    Author
  2. name
    Boerner T
    type
    Author
  3. name
    Tan BR
    type
    Author
  4. name
    Chou JF
    type
    Author
  5. name
    Gönen M
    type
    Author
  6. name
    Boucher TM
    type
    Author
  7. name
    Hauser HF
    type
    Author
  8. name
    Do RKG
    type
    Author
  9. name
    Lowery MA
    type
    Author
  10. name
    Harding JJ
    type
    Author
  11. name
    Varghese AM
    type
    Author
  12. name
    Reidy-Lagunes D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cercek A
    type
    Author
  2. name
    Boerner T
    type
    Author
  3. name
    Tan BR
    type
    Author
  4. name
    Chou JF
    type
    Author
  5. name
    Gönen M
    type
    Author
  6. name
    Boucher TM
    type
    Author
  7. name
    Hauser HF
    type
    Author
  8. name
    Do RKG
    type
    Author
  9. name
    Lowery MA
    type
    Author
  10. name
    Harding JJ
    type
    Author
  11. name
    Varghese AM
    type
    Author
  12. name
    Reidy-Lagunes D
    type
    Author
bibliography ids
  1. nci-bib-d662cca87810a851357dd26e
book metadata
content sha256
0d4adfd37e2856b9cf287815b040980ec535bebea100af3e0b08e46445944228
document type
citation
dois
  1. 10.1001/jamaoncol.2019.3718
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:31670750
immutable id
pubmed:31670750@0d4adfd37e2856b9cf287815b040980ec535bebea100af3e0b08e46445944228
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
1
name
JAMA oncology
nlm unique id
101652861
pages
60-67
volume
6
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2020 Jan 1;6(1):29-31. doi: 10.1001/jamaoncol.2019.3691.
    note
    Source null
    related pmid
    31670748
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2020 Jun 1;6(6):935. doi: 10.1001/jamaoncol.2020.0340.
    note
    Source null
    related pmid
    32271359
    relationship
    Comment in
  3. citation
    JAMA Oncol. 2020 Jun 1;6(6):935-936. doi: 10.1001/jamaoncol.2020.0343.
    note
    Source null
    related pmid
    32271367
    relationship
    Comment in
outcomes validated
false
pmid
31670750
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
93e705b09bc9b92adf729be6c4ef04f4cfcb6848330aa25c355485c436f839a5
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Jan 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31670750/
title
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Preserved source evidence · Not medical advice